Physician profile
Murray G Goldberg
NPI 1235226598
$4,722.04
in general payments reported to CMS, 2019-2025
34 companies · $1,053 in 2025
The $1,053 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $156 · 2021: $217 · 2022: $509 · 2023: $1,445 · 2024: $852 · 2025: $1,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,123 · Travel and Lodging: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.60 |
| Travel and Lodging | $226.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $695.02 | 2022-2025 | Aquabeam Robotic System |
| Coloplast Corp | $412.82 | 2019-2025 | Self-Cath, Speedicath |
| Astellas Pharma US INC | $373.83 | 2019-2025 | Xtandi, Myrbetriq |
| Axonics, INC. | $350.95 | 2022-2024 | Axonics |
| Abbvie INC. | $265.16 | 2019-2025 | |
| Antares Pharma, INC. | $233.36 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $191.54 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $190.51 | 2021-2025 | Axonics, Rezum Generator, Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $187.64 | 2023-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $186.16 | 2020-2024 | Xiaflex, Edex, Aveed |
| Endo USA, INC. | $180.58 | 2024-2025 | Xiaflex, Aveed, Edex |
| Laborie Medical Technologies Corp. | $175.94 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Tolmar, INC. | $139.74 | 2023-2025 | Eligard, Jatenzo |
| Blue Earth Diagnostics | $119.38 | 2021-2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $103.96 | 2023-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $102.72 | 2021-2024 | Jelmyto |
| Medtronic, INC. | $90.19 | 2022-2024 | Interstim, Closurefast |
| Pfizer INC. | $83.55 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $74.61 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $67.46 | 2019-2024 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $62.98 | 2024-2025 | Provenge |
| Halozyme INC | $58.00 | 2023 | |
| Sumitomo Pharma America, INC. | $53.85 | 2024-2025 | Orgovyx, Gemtesa |
| Telix Pharmaceuticals | $51.04 | 2025 | Illuccix |
| Immunitybio, INC. | $46.20 | 2024-2025 | |
| Olympus America INC. | $35.49 | 2023-2025 | Itind System |
| Rochester Medical Corporation | $34.45 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $33.17 | 2019 | |
| Hitachi Healthcare Americas Corp. | $26.04 | 2019 | |
| Zyla Life Sciences, INC. | $20.47 | 2019 | |
| Therapeuticsmd, INC. | $19.87 | 2019 | |
| Ambu INC. | $19.56 | 2024 | |
| Teleflex LLC | $17.91 | 2024 | Urolift |
| Philips North America LLC | $17.89 | 2025 | Oncology Solution |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.